Trial Outcomes & Findings for A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU (NCT NCT02003053)
NCT ID: NCT02003053
Last Updated: 2018-09-07
Results Overview
The number of patients tolerating Inspiratory Muscle Training or Sham.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
7 participants
Primary outcome timeframe
Baseline and until participant is extubated or discharged from the critical care unit (up to 1 month post-baseline)
Results posted on
2018-09-07
Participant Flow
Participant milestones
| Measure |
Inspiratory Muscle Training
In the IMT group, inspiratory muscle training will start with 30% of MIP, for five minutes twice a day with increments of 10 % (absolute) everyday. Supplemental oxygen will be given as needed. The exercise will be done seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
Sham
In the SHAM group, sham device will be used to train subjects 5 minutes twice a day, seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
|---|---|---|
|
Overall Study
STARTED
|
4
|
3
|
|
Overall Study
COMPLETED
|
4
|
3
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Inpsiratory Muscle Training
n=4 Participants
In the IMT group, inspiratory muscle training will start with 30% of MIP, for five minutes twice a day with increments of 10 % (absolute) everyday. Supplemental oxygen will be given as needed. The exercise will be done seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
Sham
n=3 Participants
In the SHAM group, sham device will be used to train subjects 5 minutes twice a day, seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
Total
n=7 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
49.0 years
STANDARD_DEVIATION 16.9 • n=4 Participants
|
54.33 years
STANDARD_DEVIATION 3.78 • n=3 Participants
|
51.29 years
STANDARD_DEVIATION 11.28 • n=7 Participants
|
|
Sex: Female, Male
Female
|
NA Participants
n=4 Participants
|
NA Participants
n=3 Participants
|
NA Participants
n=7 Participants
|
|
Sex: Female, Male
Male
|
NA Participants
n=4 Participants
|
NA Participants
n=3 Participants
|
NA Participants
n=7 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
4 participants
n=4 Participants
|
3 participants
n=3 Participants
|
7 participants
n=7 Participants
|
PRIMARY outcome
Timeframe: Baseline and until participant is extubated or discharged from the critical care unit (up to 1 month post-baseline)The number of patients tolerating Inspiratory Muscle Training or Sham.
Outcome measures
| Measure |
Inspiratory Muscle Training
n=4 Participants
In the IMT group, inspiratory muscle training will start with 30% of MIP, for five minutes twice a day with increments of 10 % (absolute) everyday. Supplemental oxygen will be given as needed. The exercise will be done seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
Sham
n=3 Participants
In the SHAM group, sham device will be used to train subjects 5 minutes twice a day, seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.
Inspiratory Muscle Trainer
|
|---|---|---|
|
Safety and Feasibility of Inspiratory Muscle Training
|
3 Participants
|
3 Participants
|
Adverse Events
Inspiratory Muscle Training Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Sham Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place